Looking Glass Lab establishes new global corporate headquarters in Vancouver, British Columbia
The digital agency specializing in non-fungible tokens (NFT) said that it is focused on rapid growth
Company
PRIVATE:[TICKER]
Procaps Group is a leading pharmaceutical and healthcare company based in Latin America with global reach, well positioned to drive regional consolidation. The Company is the largest pharmaceutical integral CDMO (iCDMO) in Latin America and top three globally in volume of softgel production capacity.1 An in-house R&D delivers unparalleled expertise and innovation with 500+ formulations, and 50+ new products per year. Six manufacturing facilities in Latin America including the first FDA-approved pharmaceutical plant on continent support its products that are sold and distributed in over 50 worldwide markets.
223 stories · page 8 of 12
The digital agency specializing in non-fungible tokens (NFT) said that it is focused on rapid growth
In pre-clinical studies, the private company’s well-tolerated suite of compounds have been found to possess potent anti-inflammatory, anti-microbial, antioxidant, and anti-tumor properties while helping to balance the gut microbiome
Through its subsidiary, EdjSports LLC, Champion Gaming provides data and analysis that includes Football Outsiders' Defense-adjusted Value Over Average (DVOA) metrics and EdjSports' Game-Winning Chance model
A recent study was carried out on the C. elegans worm, which shares many of core metabolic pathways with humans, which showed that Pan-Biome compounds significantly increased worm lifespans by up to 30%
The company also is spearheading the architecture and design of Gutter Cat Gang’s Mansion, which is planned to be a virtual metaverse-based clubhouse for holders of Gutter Cat Gang non-fungible tokens
Investments and investor services
Growth mediums are an important pillar for the mass adoption of cultured meat globally, which are critical to helping achieve material cost reductions, improved efficiencies, and consistent food products
The company, which changed its name from D Block Discoveries, focuses on developing and discovering high-grade nickel deposits and other metals that contribute to the growing electrification demand of the world economy
The recently-passed US infrastructure bill includes billions of dollars for clean energy projects
Investments and investor services
The company said it intends to closely collaborate to incubate and accelerate product development with Fiction Foods, founded by Brendan Brazier who co-developed Beyond Meat's first burger
All of HoK’s NFT collections, including GenX, are designed using three-dimensional (3D) graphics
Investments and investor services
The company said the CULT Prize further reinforces its commitment to underwriting more sustainable, environmental, and ethical solutions to the global factory farming and aquaculture crises
Investments and investor services
MeliBio has developed a scientific approach to replacing honeybees as a medium of honey production
The company said the joint venture will enable Nebari to leverage Amvest’s brand name, relationships and analytics in the natural resources sector to hopefully gain an even larger pipeline of mining opportunities
Looking Glass also announced the appointment of Neil Stevenson-Moore as its Chief Product Officer
D Block holds interests in two properties — the Manibridge Property and the Strange Property, formerly named the Whitefish Property
3D Bio-Tissues' patented technology provides an alternative source of animal leather that is also resilient to the global leather market's supply chain and trade limitations
The corporation’s common shares are expected to commence trading on the TSX Venture Exchange on or about October 20, 2021, under the symbol RV
The Toronto Venture Exchange has conditionally approved the previously announced proposed qualifying transaction between the company and Hope Well Capital Corp
NASDAQ-listed Enveric Biosciences Inc. announced on May 24, 2021, that it has entered into a definitive agreement for an all-stock transaction to acquire the biotechnology company
Enveric said the company plans to “immediately accelerate” the development of a novel psychedelic molecule for cancer-related distress